Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05994612 · ClinicalTrials.gov registry record · NA
Suicide Prevention for Substance Using Youth Experiencing Homelessness
A NA study of Suicide Prevention, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT05994612: Recruiting NA study of Suicide Prevention, sponsored by Ohio State University.
NCT05994612 is a NA study of Suicide Prevention that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 300 participants, below the 938-participant average among 21 other Suicide Prevention trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05994612, a NA study of Suicide Prevention, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Suicide is the leading cause of death among YEH and most youth do not access services that may be available to them. Therefore, this study seeks to address this gap in the research literature with the goal to identify an effective intervention that can be readily adopted by communities that serve these youth. We will test the effects of outreach-worker delivered Cognitive Therapy for Suicide Prevention (CTSP)+Services as Usual (SAU) versus SAU alone on suicidal ideation (primary outcome), substance use and depressive symptoms (secondary outcomes) at 3, 6, 9 and 12- months.
Primary Outcome
Change in suicidal ideation is measured using the Scale for Suicidal Ideation-Worst Point (SSI-W). Each item consists of three options, which are rated on a 3-point scale from 0 to 2, and each item is graded according to the intensity of the suicidality. Total scores are calculated by summing the 19 ratings, and these total scores can range from 0 to 38 with higher scores indicating worse severity.
Conditions Studied
Interventions
- BEHAVIORAL Services as Usual
- BEHAVIORAL Cognitive Therapy for Suicide Prevention
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2030-01-01 |
| Phase | NA |
What NCT05994612 shows while recruiting
NCT05994612 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 938-participant average among 21 other Suicide Prevention trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Suicide Prevention appearing as the primary indexed condition, and to 2 interventions - of which Services as Usual is the first listed.
NCT05994612 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05994612 about?
NCT05994612 is a clinical study titled "Suicide Prevention for Substance Using Youth Experiencing Homelessness". Suicide is the leading cause of death among YEH and most youth do not access services that may be available to them. Therefore, this study seeks to address this gap in the research literature with the goal to identify an effective intervention that can be readily adopted by communities that serve th...
What is the current status of trial NCT05994612?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2023-11-01. Estimated completion is 2030-01-01.
What conditions does trial NCT05994612 study?
This clinical trial studies the following conditions: Suicide Prevention.
What interventions are being tested in trial NCT05994612?
The interventions under investigation include: Services as Usual (BEHAVIORAL), Cognitive Therapy for Suicide Prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05994612?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05994612 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05994612's enrollment target sits among peer trials
300 11th of 21 higher than 11 of 21 other Suicide Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Controlled Effectiveness Trial of VA S.A.V.E.
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Virtual Reality Lethal Means Safety Training
RECRUITING · NA
-
Efficacy-Implementation Study for PC CARES in Rural Alaska
RECRUITING · NA
-
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
RECRUITING · NA
-
Suicide Prevention After Community Care Discharge
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI